Viewing Study NCT00138203


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2025-12-25 @ 4:52 PM
Study NCT ID: NCT00138203
Status: COMPLETED
Last Update Posted: 2018-01-30
First Post: 2005-08-29
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization: